Global Lurasidone Hydrochloride Generics Market Growth 2024-2030

Global Lurasidone Hydrochloride Generics Market Growth 2024-2030

Lurasidone hydrochloride generics are alternative versions of the brand-name medication lurasidone, used primarily to treat schizophrenia and bipolar disorder.

The global Lurasidone Hydrochloride Generics market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of %from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Lurasidone Hydrochloride Generics Industry Forecast” looks at past sales and reviews total world Lurasidone Hydrochloride Generics sales in 2023, providing a comprehensive analysis by region and market sector of projected Lurasidone Hydrochloride Generics sales for 2024 through 2030. With Lurasidone Hydrochloride Generics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Lurasidone Hydrochloride Generics industry.

This Insight Report provides a comprehensive analysis of the global Lurasidone Hydrochloride Generics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Lurasidone Hydrochloride Generics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Lurasidone Hydrochloride Generics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Lurasidone Hydrochloride Generics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Lurasidone Hydrochloride Generics.

United States market for Lurasidone Hydrochloride Generics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Lurasidone Hydrochloride Generics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Lurasidone Hydrochloride Generics is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Lurasidone Hydrochloride Generics players cover Accord Healthcare, Amneal, Dr. Reddy's Laboratories, MSN, Sun Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly

% in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Lurasidone Hydrochloride Generics market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
20mg per Tablet
40mg per Tablet
60mg per Tablet
80mg per Tablet
120mg per Tablet

Segmentation by Application:
Schizophrenia
Bipolar Depression

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Accord Healthcare
Amneal
Dr. Reddy's Laboratories
MSN
Sun Pharmaceuticals
Alkem
Zydus
Lupin
Alembic pharmaceuticals
Yangtze River Pharmaceutical
Qilu Pharmaceutical
SJZ No.4 Pharmaceutical
Zhejiang Huahai Pharmaceutical
Hansoh Pharma
YaoPharma
Changzhou Pharmaceutical Factory
Shandong Jewim Pharmaceutical
Hisun Pharmaceuticals
Cisen Pharmaceutical
Chia Tai Tianqing Pharmaceutical

Key Questions Addressed in this Report

What is the 10-year outlook for the global Lurasidone Hydrochloride Generics market?

What factors are driving Lurasidone Hydrochloride Generics market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Lurasidone Hydrochloride Generics market opportunities vary by end market size?

How does Lurasidone Hydrochloride Generics break out by Type, by Application?

Please note: The report will take approximately 2 business days to prepare and deliver.